Psychotropic Medication Use for Youth in Residential Treatment: A Comparison Between Youth with Monopharmacy Versus Polypharmacy
暂无分享,去创建一个
Nirbhay N. Singh | Jacqueline N. Huscroft-D’Angelo | R. Pick | J. Huefner | Annette K. Griffith | M. Epstein
[1] B. Vitiello,et al. Clinical messages from the Treatment for Adolescents With Depression Study (TADS). , 2009, The American journal of psychiatry.
[2] Ronald W. Thompson,et al. The Changing Mental Health Needs of Youth Admitted to Residential Group Home Care , 2009 .
[3] Ronald W. Thompson,et al. Psychotropic medication utilization at a group-home residential facility for children and adolescents. , 2008, Journal of child and adolescent psychopharmacology.
[4] C. McDougle,et al. Pharmacotherapy of irritability in pervasive developmental disorders. , 2008, Child and adolescent psychiatric clinics of North America.
[5] Joseph B. Ryan,et al. Special Educators' Knowledge Regarding Psychotropic Interventions for Students With Emotional and Behavioral Disorders , 2008 .
[6] A. Rush,et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. , 2008, The American journal of psychiatry.
[7] C. Walrath,et al. Clinical and Non-Clinical Characteristics Associated with Medication Use Among Children with Serious Emotional Disturbance , 2008 .
[8] D. Christakis,et al. Research Ethics in the MySpace Era , 2008, Pediatrics.
[9] D. Safer,et al. Psychotropic Medication Patterns Among Youth in Foster Care , 2008, Pediatrics.
[10] S. Preskorn,et al. Polypharmacy: When Is It Rational? , 2007, Journal of psychiatric practice.
[11] B. Vitiello. Research in child and adolescent psychopharmacology: recent accomplishments and new challenges , 2007, Psychopharmacology.
[12] A. Dean,et al. Psychotropic medication utilization in a child and adolescent mental health service. , 2006, Journal of child and adolescent psychopharmacology.
[13] S. Strakowski,et al. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[14] S. Timimi,et al. Critical Voices in Child and Adolescent Mental Health , 2006 .
[15] D. Connor. Pediatric Psychopharmacology: Fast Facts , 2006 .
[16] L. Warner,et al. Youths living away from families in the US mental health system , 2005, The Journal of Behavioral Health Services & Research.
[17] B. Burns,et al. Mental Health and Other Service Use by Youth in Therapeutic Foster Care and Group Homes , 2005 .
[18] T. Mclaughlin,et al. A naturalistic study of medication reduction in a residential treatment setting. , 2005, Journal of child and adolescent psychopharmacology.
[19] Ronald T. Brown. Recent Advances in Pharmacotherapies for the Externalizing Disorders. , 2005 .
[20] L. Price,et al. Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998. , 2004, Journal of child and adolescent psychopharmacology.
[21] H. Wagner,et al. Use of psychotropic medications by youths in therapeutic foster care and group homes. , 2004, Psychiatric services.
[22] D. Safer,et al. Concomitant psychotropic medication for youths. , 2003, The American journal of psychiatry.
[23] Andrés Martin,et al. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. , 2003, Psychiatric services.
[24] C. Binder,et al. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. , 2002, Pediatrics.
[25] S. Faraone,et al. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. , 2002, The international journal of neuropsychopharmacology.
[26] L. Greenhill. Stimulant medication treatment of children with attention deficit hyperactivity disorder. , 2002 .
[27] Marc van Bellinghen,et al. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. , 2001 .
[28] R. Barkley,et al. A Pilot Study of Methyiphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive Oppositional Defiant or Conduct Disorder , 2000, Clinical pediatrics.
[29] D. Connor,et al. Combined pharmacotherapy in children and adolescents in a residential treatment center. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[30] S. Preskorn. Should rational drug development in psychiatry target more than one mechanism of action in a single molecule , 1995 .
[31] M. Rapport,et al. Side effects of methylphenidate and desipramine alone and in combination in children. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.
[32] R. Hawkins,et al. A scale to measure restrictiveness of living environments for troubled children and youths. , 1992, Hospital & community psychiatry.